FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Cardiovascular and Renal Drugs Advisory Committee

October 16, 2007

 Briefing Information

Regulatory considerations for extending the use of phosphate binders to the pre-dialysis population.

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

GENZYME CORPORATION, FRESENIUS MEDICAL CARE NORTH AMERICA AND SHIRE PHARMACEUTICALS 

Briefing Document   (pdf)

FDA

The FDA has no formal briefing document for this Advisory Committee meeting

Page last updated October 11, 2007 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management